A Phase II Study of Ivonescimab Combined With Intraperitoneal Paclitaxel in Patients With High-Grade Metastatic Appendiceal Adenocarcinoma (AA)

NCT07753824 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Phase II
Ivonescimab
Intraperitoneal
Paclitaxel
High Grade Metastatic
Appendiceal Adenocarcinoma

Interventions

DRUG: Ivonescimab
DRUG: IP PTX

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]